A roundtable event hosted by IPPOSI on medication compliance and adherence took place in Dublin on June 27th. This event heard that up to 50% of patients with serious long-term medical conditions do not take their medication or take it incorrectly.
The reasons for poor medication adherence are complex and can include cost, poor communication and education about the medication from healthcare workers, as well as fear about side effects and a lack of awareness of the potential risks if the medication is not taken. Kitty O’Connor, CEO of the Alpha One Foundation, provided a patient voice at the meeting which heard contributions from a number of expert speakers.
KEY CONTRIBUTORS;
Dr Ambrose McLoughlin, Secretary General of the Department of Health
Dr Roisin Adams, National Centre for Pharmacoeconomics
Ms Kitty O’Connor, Chief Executive, Alpha One Foundation
Dr Frank Doyle, Division of Population Health Sciences (Psychology), RCSI
Dr Colm Galligan, Medical Director, MSD
Prof Brian Caulfield, ARCH & INSIGHT Research Centres, UCD
Ms Naomi Fitzgibbon, Cancer Information Service, Irish Cancer Society
The event was addressed by Department of Health secretary general Dr. Ambrose McLoughlin who announced new prescribing guidance would be issued to doctors later this year. He also announced that the Health Information Bill which will provide a legislative framework for improved guidance of health information will be published by his department by the end of October. Coverage of this event appeared in the Irish Times Health Supplement on July 2nd, and a full outcome report is to be published by IPPOSI which will identify areas of consensus and those areas which require further debate.
Info Centre
WhatisAlpha-1Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
WhatisAlpha-1AntitrypsinDeficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
HowDoIGetTested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie
Medication Compliance and Adherence Meeting
A roundtable event hosted by IPPOSI on medication compliance and adherence took place in Dublin on June 27th. This event heard that up to 50% of patients with serious long-term medical conditions do not take their medication or take it incorrectly.
The reasons for poor medication adherence are complex and can include cost, poor communication and education about the medication from healthcare workers, as well as fear about side effects and a lack of awareness of the potential risks if the medication is not taken. Kitty O’Connor, CEO of the Alpha One Foundation, provided a patient voice at the meeting which heard contributions from a number of expert speakers.
KEY CONTRIBUTORS;
The event was addressed by Department of Health secretary general Dr. Ambrose McLoughlin who announced new prescribing guidance would be issued to doctors later this year. He also announced that the Health Information Bill which will provide a legislative framework for improved guidance of health information will be published by his department by the end of October. Coverage of this event appeared in the Irish Times Health Supplement on July 2nd, and a full outcome report is to be published by IPPOSI which will identify areas of consensus and those areas which require further debate.
Info Centre
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
How Do I Get Tested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie